These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11118739)

  • 41. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model.
    Ramamoorthy S; Opriessnig T; Pal N; Huang FF; Meng XJ
    Vet Microbiol; 2011 Jan; 147(1-2):49-58. PubMed ID: 20637549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a major quantitative trait locus for porcine reproductive and respiratory syndrome (PRRS) resistance on response to coinfection with PRRS virus and porcine circovirus type 2b (PCV2b) in commercial pigs, with or without prior vaccination for PRRS.
    Dunkelberger JR; Serão NV; Niederwerder MC; Kerrigan MA; Lunney JK; Rowland RR; Dekkers JC
    J Anim Sci; 2017 Feb; 95(2):584-598. PubMed ID: 28380604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
    Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
    Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena.
    Trus I; Bonckaert C; van der Meulen K; Nauwynck HJ
    Vaccine; 2014 May; 32(25):2995-3003. PubMed ID: 24709589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental reproduction of severe disease in CD/CD pigs concurrently infected with type 2 porcine circovirus and porcine reproductive and respiratory syndrome virus.
    Harms PA; Sorden SD; Halbur PG; Bolin SR; Lager KM; Morozov I; Paul PS
    Vet Pathol; 2001 Sep; 38(5):528-39. PubMed ID: 11572560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Type 2 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against the 2010 isolate of Vietnamese highly pathogenic PRRSV challenge in pigs.
    Iseki H; Kawashima K; Tung N; Inui K; Ikezawa M; Shibahara T; Yamakawa M
    J Vet Med Sci; 2017 Apr; 79(4):765-773. PubMed ID: 28239040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis.
    Blecha F; Reddy DN; Chitko-McKown CG; McVey DS; Chengappa MM; Goodband RD; Nelssen JL
    Vet Immunol Immunopathol; 1995 Feb; 44(3-4):329-46. PubMed ID: 7747410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model.
    Pileri E; Gibert E; Soldevila F; García-Saenz A; Pujols J; Diaz I; Darwich L; Casal J; Martín M; Mateu E
    Vet Microbiol; 2015 Jan; 175(1):7-16. PubMed ID: 25439650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal and morphologic characterization of the distribution of porcine reproductive and respiratory syndrome virus (PRRSV) by in situ hybridization in pigs infected with isolates of PRRSV that differ in virulence.
    Haynes JS; Halbur PG; Sirinarumitr T; Paul PS; Meng XJ; Huffman EL
    Vet Pathol; 1997 Jan; 34(1):39-43. PubMed ID: 9150544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
    Charerntantanakul W; Pongjaroenkit S
    Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring of porcine reproductive and respiratory syndrome virus infection in boars.
    Shin J; Torrison J; Choi CS; Gonzalez SM; Crabo BG; Molitor TW
    Vet Microbiol; 1997 Apr; 55(1-4):337-46. PubMed ID: 9220631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of experimental models for Streptococcus suis infection of conventional pigs.
    Pallarés FJ; Halbur PG; Schmitt CS; Roth JA; Opriessnig T; Thomas PJ; Kinyon JM; Murphy D; Frank DE; Hoffman LJ
    Can J Vet Res; 2003 Jul; 67(3):225-8. PubMed ID: 12889730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.